Home › Atherosclerosis › Virginia › Richmond
Atherosclerosis clinical trials in Richmond, VA
5 studies for Atherosclerosis are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Dominion Medical Associates, Inc., Richmond
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Richmond V.A. Medical Center, Richmond
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Richmond
- Research Site, Hopewell · 20 mi away
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Vcu Health, Richmond
- Heart Care Associates P C, Hopewell · 20 mi away
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Omaha, NE6 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Cardiovascular Disease13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Metastatic Cancer12 studies
- Melanoma11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.